冠状动脉CT血管成像中心外异常发现的临床与经济影响
这项回顾性观察性横断面研究纳入2012年1月至2020年3月单中心接受冠状动脉CT血管成像(CCTA)的4340例患者,其中687例(15.8%)发现至少一项显著心外异常,共717项异常。
要点
- CCTA中心外异常常见(15.8%),以肺结节和囊肿最多(43.1%)。
- 仅0.3%全人群需治疗,0.1%因腺癌行肺切除。
核心结论
- CCTA中心外异常常见但需治疗者极少,识别与随访成本高,应重新审视在资源有限医疗体系中常规宽视野筛查心外异常的方式。
研究设计与样本
- 回顾性观察性横断面研究,纳入2012年1月至2020年3月单中心接受CCTA的患者共4340例。
- 入选≥1项显著心外异常的患者,记录临床随访、检查与治疗并计算成本。
主要发现
- 687例(15.8%)发现717项心外异常,年龄62±12岁,男性336例(49%)。
- 162项(23.6%)异常为已知,肺结节和囊肿最常见(296项,43.1%)。
- 292例(42.5%)进行了临床和/或影像随访,14例(全人群0.3%)需治疗,其中6例(0.1%)因腺癌行肺切除。
- 除2例腺癌外,所有异常均可在限制性心脏视野中识别。
关键数值与推荐
- 报告心外异常成本为20英镑,随访成本为33英镑,合计每患者53英镑。
临床怎么用
- CCTA报告心外异常时需权衡成本与获益,尤其在大范围视野筛查中。
- 多数需治疗的心外异常可在限制性心脏视野中识别,或可优化报告策略。
局限性
- 单中心回顾性研究,结果外推需谨慎。
- 未报告随访持续时间及成本计算的具体细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: When reporting coronary CT angiography (CCTA), extracardiac structures are routinely assessed, usually on a wide field-of-view (FOV) reconstruction. We performed a retrospective observational cross-sectional study to investigate the impact of incidental extracardiac abnormalities on resource utilisation and treatment, and cost-effectiveness. METHODS: All patients undergoing CCTA at a single institution between January 2012 and March 2020 were identified. The indication for CCTA was chest pain or dyspnoea in >90%. Patients with ≥1 significant extracardiac findings were selected. Clinical follow-up, investigations and treatment were documented, and costs were calculated. RESULTS: 4340 patients underwent CCTA; 717 extracardiac abnormalities were identified in 687 individuals (15.8%; age 62±12 years; male 336, 49%). The abnormality was already known in 162 (23.6%). Lung nodules and cysts were the most common abnormalities (296, 43.1%). Clinical and/or imaging follow-up was pursued in 292 patients (42.5%). Treatment was required by 14 patients (0.3% of the entire population), including lung resection for adenocarcinoma in six (0.1%). All but two abnormalities (both adenocarcinomas) were identifiable on the limited cardiac FOV. The cost of reporting (£20) and follow-up (£33) of extracardiac abnormalities was £53 per patient. The cost per discounted quality-adjusted life year was £23 930, increasing to £46 674 for reporting the wide FOV rather than the cardiac FOV alone. CONCLUSIONS: Extracardiac abnormalities are common on CCTA, but identification and follow-up are costly. The few requiring treatment are usually identifiable without review of the wide FOV. The way in which CCTAs are scrutinised for extracardiac abnormalities in a resource-limited healthcare system should be questioned.
引用
- Kelion A, Sabharwal N, Holdsworth D, et al. Clinical and economic impact of extracardiac lesions on coronary CT angiography. Heart. 2022. PMID: 35318255. doi:10.1136/heartjnl-2021-320698
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。